Manufacturing

Articles

Oxford Genetics increased its laboratory space to 5700 sq. ft. with a move to a new location at Oxford Science Park.

Oxford Genetics Opens New Facility to Support R&D in Cell and Gene Therapy

The Cell and Gene Therapy Catapult released a review of their third annual survey of GMP cell and gene therapy facilities in the United Kingdom.

Report Shows Increase in Capacity in Cell and Gene Therapy Manufacturing in the UK

Synpromics announced collaborations with Avalanche Biotechnologies and Applied Genetic Technologies Corporation to use synthetic promoters to develop gene therapies, including adeno-associated virus technology for treating eye diseases.

Synpromics Collaborates on Gene Therapies

GSK announces it will invest $95 million to launch a US-based non-profit research institute, Altius, to research technologies and approaches in understanding gene control.

GSK Invests $95 Million in Gene Control Research

The University of Pennsylvania announces that it will collaborate with WuXi AppTech to research and develop gene vectors derived from recombinant viruses.

Penn Announces Gene Therapy Collaboration with WuXi

The exclusive manufacturing collaboration will establish production for adeno-associated virus gene-therapy treatments incorporating REGENXBIO’s NAV Technology.

REGENXBIO and WuXi AppTec Collaborate on Gene Therapy Manufacturing

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Genzyme will partner with Voyager Therapeutics for the discovery, development, and commercialization of novel gene therapies for central nervous system disorders.

Genzyme Announces $845-Million Gene Therapy Deal

On December 8, Pfizer announced that it will establish a research program in gene therapy, and collaborate with Spark Therapeutics in Philadelphia, to develop potential gene therapy treatments for hemophilia.

Manufacturing, Gene Therapies